These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8884232)

  • 1. Alterations of protein mono-ADP-ribosylation and diabetic neuropathy: a novel pharmacological approach.
    Gorio A; Donadoni ML; Finco C; Borella F; Di Giulio AM
    Eur J Pharmacol; 1996 Sep; 311(1):21-8. PubMed ID: 8884232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous mono-ADP-ribosylation in retina and peripheral nervous system. Effects of diabetes.
    Gorio A; Donadoni ML; Finco C; Di Giulio AM
    Adv Exp Med Biol; 1997; 419():289-95. PubMed ID: 9193668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental diabetic neuropathy. Inhibition of protein mono-ADP-ribosylation prevents reduction of substance P axonal transport.
    Donadoni ML; Gavezzotti R; Borella F; Di Giulio AM; Gorio A
    J Pharmacol Exp Ther; 1995 Jul; 274(1):570-6. PubMed ID: 7542340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide-sensitive protein ADP-ribosylation is altered in rat diabetic neuropathy.
    Gorio A; Donadoni ML; Di Giulio AM
    J Neurosci Res; 1995 Feb; 40(3):420-6. PubMed ID: 7745637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of endogenous mono-ADP-ribosylation of cardiac proteins via anti-ADP-ribosylarginine immunoreactivity.
    Schwab CJ; Colville MJ; Fullerton AT; McMahon KK
    Proc Soc Exp Biol Med; 2000 Apr; 223(4):389-96. PubMed ID: 10721009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contribution of endogenous mono-ADP-ribosylation to kindling-induced epileptogenesis.
    Suzuki K; Iwasa H; Kikuchi S; Sato T; Miyake M; Morinaga N; Noda M
    Brain Res; 1997 Jan; 745(1-2):109-13. PubMed ID: 9037398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of endogenous ADP-ribosylation in rat brain.
    Williams MB; Li X; Gu X; Jope RS
    Brain Res; 1992 Oct; 592(1-2):49-56. PubMed ID: 1333343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy.
    Li F; Szabó C; Pacher P; Southan GJ; Abatan OI; Charniauskaya T; Stevens MJ; Obrosova IG
    Diabetologia; 2004 Apr; 47(4):710-7. PubMed ID: 15298348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of high glucose-induced protein mono-ADP-ribosylation restores neuritogenesis and sodium-pump activity in SY5Y neuroblastoma cells.
    Di Giulio AM; Lesma E; Germani E; Gorio A
    J Neurosci Res; 1999 Sep; 57(5):663-9. PubMed ID: 10462690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic neuropathy in the rat: 1. Alcar augments the reduced levels and axoplasmic transport of substance P.
    Di Giulio AM; Lesma E; Gorio A
    J Neurosci Res; 1995 Feb; 40(3):414-9. PubMed ID: 7538169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy.
    Kishi Y; Schmelzer JD; Yao JK; Zollman PJ; Nickander KK; Tritschler HJ; Low PA
    Diabetes; 1999 Oct; 48(10):2045-51. PubMed ID: 10512372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role of intracellular mono-ADP-ribosylation in cancer biology.
    Scarpa ES; Fabrizio G; Di Girolamo M
    FEBS J; 2013 Aug; 280(15):3551-62. PubMed ID: 23590234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degeneration of the Golgi and neuronal loss in dorsal root ganglia in diabetic BioBreeding/Worcester rats.
    Kamiya H; Zhang W; Sima AA
    Diabetologia; 2006 Nov; 49(11):2763-74. PubMed ID: 17047923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of hippocampal synaptic proteins by nitric oxide-stimulated ADP ribosylation.
    Sullivan BM; Wong S; Schuman EM
    Learn Mem; 1997; 3(5):414-24. PubMed ID: 10456108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy.
    Murakawa Y; Zhang W; Pierson CR; Brismar T; Ostenson CG; Efendic S; Sima AA
    Diabetes Metab Res Rev; 2002; 18(6):473-83. PubMed ID: 12469361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid uptake by dorsal root ganglia from streptozotocin-diabetic rats.
    Thomas PK; Wright DW; Tzebelikos E
    J Neurol Neurosurg Psychiatry; 1984 Sep; 47(9):912-6. PubMed ID: 6207270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization and partial characterization of ADP-ribosylation products in hearts from adult and neonatal rats.
    Piron KJ; McMahon KK
    Biochem J; 1990 Sep; 270(3):591-7. PubMed ID: 2173547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Talin immunogold density increases in sciatic nerve of diabetic rats after nerve growth factor treatment.
    Renno WM; Saleh F; Klepacek I; Al-Awadi F
    Medicina (Kaunas); 2006; 42(2):147-63. PubMed ID: 16528132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetyl-L-carnitine prevents substance P loss in the sciatic nerve and lumbar spinal cord of diabetic animals.
    Di Giulio AM; Gorio A; Bertelli A; Mantegazza P; Ferraris L; Ramacci MT
    Int J Clin Pharmacol Res; 1992; 12(5-6):243-6. PubMed ID: 1284499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanical hyperalgesia in rat models of systemic and local hyperglycemia.
    Dobretsov M; Hastings SL; Romanovsky D; Stimers JR; Zhang JM
    Brain Res; 2003 Jan; 960(1-2):174-83. PubMed ID: 12505670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.